Seipel, K.;                     Shaforostova, I.;                     Nilius, H.;                     Bacher, U.;                     Pabst, T.    
        Clinical Impact of CTLA-4 Single-Nucleotide Polymorphism in DLBCL Patients Treated with CAR-T Cell Therapy. Curr. Oncol. 2025, 32, 425.
    https://doi.org/10.3390/curroncol32080425
    AMA Style
    
                                Seipel K,                                 Shaforostova I,                                 Nilius H,                                 Bacher U,                                 Pabst T.        
                Clinical Impact of CTLA-4 Single-Nucleotide Polymorphism in DLBCL Patients Treated with CAR-T Cell Therapy. Current Oncology. 2025; 32(8):425.
        https://doi.org/10.3390/curroncol32080425
    
    Chicago/Turabian Style
    
                                Seipel, Katja,                                 Inna Shaforostova,                                 Henning Nilius,                                 Ulrike Bacher,                                 and Thomas Pabst.        
                2025. "Clinical Impact of CTLA-4 Single-Nucleotide Polymorphism in DLBCL Patients Treated with CAR-T Cell Therapy" Current Oncology 32, no. 8: 425.
        https://doi.org/10.3390/curroncol32080425
    
    APA Style
    
                                Seipel, K.,                                 Shaforostova, I.,                                 Nilius, H.,                                 Bacher, U.,                                 & Pabst, T.        
        
        (2025). Clinical Impact of CTLA-4 Single-Nucleotide Polymorphism in DLBCL Patients Treated with CAR-T Cell Therapy. Current Oncology, 32(8), 425.
        https://doi.org/10.3390/curroncol32080425